1hvr: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "1hvr" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1hvr.png|left|200px]] | [[Image:1hvr.png|left|200px]] | ||
{{STRUCTURE_1hvr| PDB=1hvr | SCENE= }} | {{STRUCTURE_1hvr| PDB=1hvr | SCENE= }} | ||
===RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS=== | ===RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS=== | ||
{{ABSTRACT_PUBMED_8278812}} | {{ABSTRACT_PUBMED_8278812}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Virus protease]] | *[[Virus protease|Virus protease]] | ||
==Reference== | ==Reference== | ||
Revision as of 10:16, 25 July 2012
RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
Template:ABSTRACT PUBMED 8278812
About this Structure
1hvr is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See Also
Reference
- Lam PY, Jadhav PK, Eyermann CJ, Hodge CN, Ru Y, Bacheler LT, Meek JL, Otto MJ, Rayner MM, Wong YN, et al.. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science. 1994 Jan 21;263(5145):380-4. PMID:8278812
- Ala PJ, Huston EE, Klabe RM, McCabe DD, Duke JL, Rizzo CJ, Korant BD, DeLoskey RJ, Lam PY, Hodge CN, Chang CH. Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors. Biochemistry. 1997 Feb 18;36(7):1573-80. PMID:9048541 doi:10.1021/bi962234u
